Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

NYSE:LRN - US86333M1080 - Common Stock

169.79 USD
+3.42 (+2.06%)
Last: 8/26/2025, 5:48:41 PM
169.79 USD
0 (0%)
After Hours: 8/26/2025, 5:48:41 PM
Fundamental Rating

7

LRN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. LRN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LRN is growing strongly while it is still valued neutral. This is a good combination! With these ratings, LRN could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

LRN had positive earnings in the past year.
In the past year LRN had a positive cash flow from operations.
Each year in the past 5 years LRN has been profitable.
LRN had a positive operating cash flow in each of the past 5 years.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 12.55%, LRN belongs to the top of the industry, outperforming 88.73% of the companies in the same industry.
Looking at the Return On Equity, with a value of 19.46%, LRN belongs to the top of the industry, outperforming 85.92% of the companies in the same industry.
LRN has a better Return On Invested Capital (15.98%) than 92.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LRN is in line with the industry average of 10.23%.
The last Return On Invested Capital (15.98%) for LRN is above the 3 year average (11.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.55%
ROE 19.46%
ROIC 15.98%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 11.97%, LRN is in the better half of the industry, outperforming 70.42% of the companies in the same industry.
LRN's Profit Margin has improved in the last couple of years.
LRN has a better Operating Margin (17.44%) than 81.69% of its industry peers.
In the last couple of years the Operating Margin of LRN has grown nicely.
LRN has a Gross Margin of 39.24%. This is comparable to the rest of the industry: LRN outperforms 46.48% of its industry peers.
LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.44%
PM (TTM) 11.97%
GM 39.24%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LRN is creating value.
LRN has more shares outstanding than it did 1 year ago.
LRN has more shares outstanding than it did 5 years ago.
LRN has a better debt/assets ratio than last year.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 8.21 indicates that LRN is not in any danger for bankruptcy at the moment.
The Altman-Z score of LRN (8.21) is better than 91.55% of its industry peers.
LRN has a debt to FCF ratio of 1.35. This is a very positive value and a sign of high solvency as it would only need 1.35 years to pay back of all of its debts.
LRN has a better Debt to FCF ratio (1.35) than 84.51% of its industry peers.
LRN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of LRN (0.31) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.35
Altman-Z 8.21
ROIC/WACC1.82
WACC8.77%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

LRN has a Current Ratio of 5.39. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
LRN has a Current ratio of 5.39. This is amongst the best in the industry. LRN outperforms 92.96% of its industry peers.
A Quick Ratio of 5.27 indicates that LRN has no problem at all paying its short term obligations.
LRN has a better Quick ratio (5.27) than 92.96% of its industry peers.
Industry RankSector Rank
Current Ratio 5.39
Quick Ratio 5.27
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

7

3. Growth

3.1 Past

LRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.91%, which is quite impressive.
The Earnings Per Share has been growing by 58.07% on average over the past years. This is a very strong growth
LRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.90%.
The Revenue has been growing by 18.24% on average over the past years. This is quite good.
EPS 1Y (TTM)28.91%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%-27.46%
Revenue 1Y (TTM)17.9%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%22.36%

3.2 Future

The Earnings Per Share is expected to grow by 18.94% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.06% on average over the next years. This is quite good.
EPS Next Y31.37%
EPS Next 2Y23.22%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue Next Year12.55%
Revenue Next 2Y10.05%
Revenue Next 3Y9.78%
Revenue Next 5Y9.06%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.20 indicates a quite expensive valuation of LRN.
Compared to the rest of the industry, the Price/Earnings ratio of LRN is on the same level as its industry peers.
LRN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 21.47, which indicates a rather expensive current valuation of LRN.
Based on the Price/Forward Earnings ratio, LRN is valued a bit cheaper than 63.38% of the companies in the same industry.
LRN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.2
Fwd PE 21.47
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

61.97% of the companies in the same industry are more expensive than LRN, based on the Enterprise Value to EBITDA ratio.
71.83% of the companies in the same industry are more expensive than LRN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.87
EV/EBITDA 12.31
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

LRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of LRN may justify a higher PE ratio.
LRN's earnings are expected to grow with 18.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)0.49
EPS Next 2Y23.22%
EPS Next 3Y18.94%

0

5. Dividend

5.1 Amount

LRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STRIDE INC

NYSE:LRN (8/26/2025, 5:48:41 PM)

After market: 169.79 0 (0%)

169.79

+3.42 (+2.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners108.35%
Inst Owner Change-0.75%
Ins Owners2.68%
Ins Owner Change2.99%
Market Cap7.41B
Analysts83.64
Price Target167.58 (-1.3%)
Short Float %10.07%
Short Ratio6.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.01%
Min EPS beat(2)-41.53%
Max EPS beat(2)-0.5%
EPS beat(4)2
Avg EPS beat(4)73.2%
Min EPS beat(4)-41.53%
Max EPS beat(4)331.54%
EPS beat(8)6
Avg EPS beat(8)57.76%
EPS beat(12)9
Avg EPS beat(12)17.68%
EPS beat(16)12
Avg EPS beat(16)16.02%
Revenue beat(2)2
Avg Revenue beat(2)3.14%
Min Revenue beat(2)2.93%
Max Revenue beat(2)3.34%
Revenue beat(4)4
Avg Revenue beat(4)4.15%
Min Revenue beat(4)2.13%
Max Revenue beat(4)8.2%
Revenue beat(8)7
Avg Revenue beat(8)3.01%
Revenue beat(12)11
Avg Revenue beat(12)2.73%
Revenue beat(16)15
Avg Revenue beat(16)3.37%
PT rev (1m)1.13%
PT rev (3m)2.04%
EPS NQ rev (1m)1.26%
EPS NQ rev (3m)12.98%
EPS NY rev (1m)5.64%
EPS NY rev (3m)6.31%
Revenue NQ rev (1m)4.09%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)3.89%
Revenue NY rev (3m)4.01%
Valuation
Industry RankSector Rank
PE 28.2
Fwd PE 21.47
P/S 3.08
P/FCF 19.87
P/OCF 17.12
P/B 5.01
P/tB 6.85
EV/EBITDA 12.31
EPS(TTM)6.02
EY3.55%
EPS(NY)7.91
Fwd EY4.66%
FCF(TTM)8.54
FCFY5.03%
OCF(TTM)9.92
OCFY5.84%
SpS55.13
BVpS33.91
TBVpS24.77
PEG (NY)0.9
PEG (5Y)0.49
Profitability
Industry RankSector Rank
ROA 12.55%
ROE 19.46%
ROCE 21.07%
ROIC 15.98%
ROICexc 31.63%
ROICexgc 52.41%
OM 17.44%
PM (TTM) 11.97%
GM 39.24%
FCFM 15.5%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexcg growth 3Y30.19%
ROICexcg growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.35
Debt/EBITDA 0.86
Cap/Depr 52.33%
Cap/Sales 2.49%
Interest Coverage 45.89
Cash Conversion 81.02%
Profit Quality 129.47%
Current Ratio 5.39
Quick Ratio 5.27
Altman-Z 8.21
F-Score7
WACC8.77%
ROIC/WACC1.82
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)28.91%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%-27.46%
EPS Next Y31.37%
EPS Next 2Y23.22%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue 1Y (TTM)17.9%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%22.36%
Revenue Next Year12.55%
Revenue Next 2Y10.05%
Revenue Next 3Y9.78%
Revenue Next 5Y9.06%
EBIT growth 1Y68.1%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year43.28%
EBIT Next 3Y22.23%
EBIT Next 5Y18.08%
FCF growth 1Y71.64%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y55.24%
OCF growth 3Y27.9%
OCF growth 5Y40.03%